Chan Simon T B, Chan C K, Tse M L
Department of Accident and Emergency, United Christian Hospital, Kwun Tong, Hong Kong.
Hong Kong Poison Information Centre, United Christian Hospital, Kwun Tong, Hong Kong.
Hong Kong Med J. 2015 Oct;21(5):389-93. doi: 10.12809/hkmj144481. Epub 2015 Jul 31.
To evaluate the failure rate of the 150-treatment line for paracetamol overdose in Hong Kong, and the impact if the treatment threshold was lowered.
Public hospitals, Hong Kong.
All patients with acute paracetamol overdose reported to the Hong Kong Poison Information Centre from 1 January 2011 to 31 December 2013 were studied and analysed for the timed serum paracetamol concentration and their relationship to different treatment lines. Presence of significant liver injury following paracetamol overdose was documented. The potential financial burden of different treatment lines implemented locally was estimated.
Of 893 patients, 187 (20.9%) had serum paracetamol concentration above the 150-treatment line, 112 (12.5%) had serum paracetamol concentration between the 100- and 150-treatment lines, and 594 (66.5%) had serum paracetamol level below the 100-treatment line. Of the 25 (2.8%) patients who developed significant liver injury, two were between the 100- and 150-treatment lines, and the other two were below the 100-treatment line. The failure rate of the 150-treatment line was 0.45%. Lowering the treatment threshold to the 100-treatment line might lower the failure rate of the treatment nomogram to 0.22% but approximately 37 more patients per year would need to be treated. It would incur an additional annual cost of HK$189 131 (US$24 248), and an additional 1.83 anaphylactoid reactions per year. The number needed-to-treat to potentially reduce one significant liver injury is 112.
Lowering the treatment threshold of paracetamol overdose may reduce the treatment-line failure rate. Nonetheless such a decision must be balanced against the excess in treatment complications and health care resources.
评估香港地区对乙酰氨基酚过量治疗的150治疗线的失败率,以及降低治疗阈值的影响。
香港公立医院。
对2011年1月1日至2013年12月31日向香港毒物信息中心报告的所有急性对乙酰氨基酚过量患者进行研究,分析其血清对乙酰氨基酚浓度随时间的变化及其与不同治疗线的关系。记录对乙酰氨基酚过量后出现的严重肝损伤情况。估算本地实施不同治疗线的潜在财务负担。
893例患者中,187例(20.9%)血清对乙酰氨基酚浓度高于150治疗线,112例(12.5%)血清对乙酰氨基酚浓度在100至150治疗线之间,594例(66.5%)血清对乙酰氨基酚水平低于100治疗线。在出现严重肝损伤的25例(2.8%)患者中,2例在100至150治疗线之间,另外2例低于100治疗线。150治疗线的失败率为0.45%。将治疗阈值降低至100治疗线可能会使治疗图谱的失败率降至0.22%,但每年需要多治疗约37例患者。这将导致每年额外花费189,131港元(24,248美元),每年额外出现1.83例类过敏反应。为了潜在地减少一例严重肝损伤,所需治疗人数为112例。
降低对乙酰氨基酚过量的治疗阈值可能会降低治疗线失败率。然而,这一决定必须与治疗并发症和医疗资源的增加相权衡。